Injections for oral lesions may reduce need for surgery

The injection of immunotherapy directly into precancerous oral lesions may reduce risk for progression to cancer and help some patients avoid potentially debilitating surgery, according to study results.
The size of treated lesions decreased on average by more than half and a majority remained cancer free after 1 year, findings presented at American Association for Cancer Research Annual Meeting showed. Researchers observed no dose-limiting or systemic immune-related toxicities.
If validated in follow-up trials, the approach could represent a paradigm shift, according to lead author Moran Amit,

